ixekizumab - CAS 1143503-69-8
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C6492H10012N1728O2028S46
Molecular Weight:
146200
COA:
Inquire
Targets:
IL-17A
Description:
Ixekizumab is a humanized monoclonal antibody that inhibits interleukin 17A (IL-17A). It was approved by FDA for the treatment of moderate to severe plaque psoriasis in adult patients.
Publictions citing BOC Sciences Products
  • >> More
Brife Description:
humanized monoclonal antibody, IL-17A, plaque psoriasis
Synonyms:
Taltz
MSDS:
Inquire
Application:
the treatment of plaque psoriasis
Current Developer:
Lilly
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Quick Inquiry

Verification code

Featured Items